---
title: "Australia's Cochlear slumps as HY results, outlook disappoint"
date: "2025-02-14 11:39:52"
summary: "** Cochlear slides as much as 14.1% to A$261.73; set for worst day since March 2020 ** Stock at lowest level since November 2023 ** Hearing implants maker reports HY underlying NPAT of A$206 mln ($206 mln), missing Visible Alpha consensus of A$209.3 mln** Expects FY underlying net profit to..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* Cochlear slides as much as 14.1% to A$261.73; set for worst day since March 2020

\*\* Stock at lowest level since November 2023

\*\* Hearing implants maker reports HY underlying NPAT of A$206 mln ($206 mln), missing Visible Alpha consensus of A$209.3 mln

\*\* Expects FY underlying net profit to be at lower end of A$410 mln-A$430 mln forecast range

\*\* UBS says, "New expectations for being at lower end of profit guidance could cause concern or it could just be a blip if services revenue in fiscal 2026 can pick up again with new product launches"

\*\* Expects single-digit decline in FY services revenue

\*\* COH among worst performers on ASX 200 benchmark index

\*\* Stock, one of the priciest in the country, down ~9% YTD

($1 = $1.0000)

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3P5085:0-australia-s-cochlear-slumps-as-hy-results-outlook-disappoint/)
